Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2009; 34(2): 187-190


Effectiveness and safety of Levonorgestrel Releasing Intrauterine System in treatment of menorrhagia secondary to oral anticoagulations and chronic liver disease

Abeera Choudry, Ayesha Malik, Humaira Choudry, Naila Bangish, Naheed Hayat.




Abstract

Objective
To determine whether the levonorgesterol releasing intra-uterine contraceptive device
can safely reduce menstrual blood loss and improve quality of life in patients with
bleeding disorders and those on oral anticoagulation.
Methods
Patients presenting with menorrhagia, without pelvic pathology and suffering from
bleeding disorder or using oral anticoagulants had Mirena inserted at Military Hospital,
Rawalpindi. Baseline hemoglobin and menstrual blood loss was evaluated using pictorial
blood assessment chart. Follow up hemoglobin and menstrual assessments were
performed at 3, 6 and 12 months. At 12 months, patient satisfaction was assessed.
Results
Eighteen patients with bleeding disorders (3 chronic liver disease and 6 on
anticoagulation with warfarin) were included in the study. One patient was lost to follow
up after 3 months. Remaining were followed for one year. Continuity rate was 91% at
one year. Mirena resulted in decrease in menstrual blood loss by 60% at 3 months, 70%
at 6 months and 85 % at one year (p

Key words: LNG-IUS, menorrahagia, bleeding disorders, CLD.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.